This federal contract award, SPE2DB22D3401|SPE2DB25FT1AM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,919.92 firm fixed-price delivery order is for 30-count packages of the generic drug ondansetron hydrochloride 4 mg tablets. The contract has a completion date of December 6, 2024 and was awarded on December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded without any set-aside designation, indicating open competition.
Generated 3/6/25, 9:52 AM